Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Hodgkin's Disease 2018 NIAID 5R01AI114557-04 Neutralizing Antibodies in Acute and Persistent Epstein-Barr Virus Infection WANG, FREDERICK BRIGHAM AND WOMEN'S HOSPITAL MA $593,287
Hodgkin's Disease 2018 NCI 5R01CA203923-02 IRF-1: a brake to limit gammaherpesvirus infection and pathogenesis TARAKANOVA, VERA MEDICAL COLLEGE OF WISCONSIN WI $352,275
Hodgkin's Disease 2018 NCI 5R01CA157644-09 Targeted activation of autoimmune checkpoints in B cell malignancies MUSCHEN, MARKUS BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $410,875
Hodgkin's Disease 2018 NCI 2P50CA107399-11A1 5662 Therapy-related leukemia following autologous transplantation for lymphoma BHATIA, SMITA BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $676,409
Hodgkin's Disease 2018 NCI 2P50CA107399-11A1 5663 Targeted immunotherapy for relapsed/refractory Hodgkin lymphoma CHEN, ROBERT BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $336,786
Hodgkin's Disease 2018 NCI 5R01CA206019-03 Host factors, tumor microenvironment and survival in a multiethnic study of Hodgkin lymphoma patients COZEN, WENDY UNIVERSITY OF SOUTHERN CALIFORNIA CA $802,716
Hodgkin's Disease 2018 NIAID 5R01AI113130-03 New Therapeutics for Post-Transplant Lymphoproliferative Disorder MARTINEZ, OLIVIA STANFORD UNIVERSITY CA $398,138
Hodgkin's Disease 2018 NCI 5R01CA161026-08 Targetable Immune Evasion Pathways in Hodgkin Lymphoma SHIPP, MARGARET DANA-FARBER CANCER INST MA $373,399
Hodgkin's Disease 2018 NCI 5K24CA184039-05 Molecularly Targeted Therapy for Lymphoma GOPAL, AJAY UNIVERSITY OF WASHINGTON WA $171,401
Hodgkin's Disease 2018 NCI 5P30CA006973-55 8084 Hematologic Malignancies and BMT Program - 02 AMBINDER, RICHARD JOHNS HOPKINS UNIVERSITY MD $55,373
Hodgkin's Disease 2018 NCI 3R01CA203923-02S1 IRF-1: a brake to limit gammaherpesvirus infection and pathogenesis TARAKANOVA, VERA MEDICAL COLLEGE OF WISCONSIN WI $58,868
Hodgkin's Disease 2018 NCI 5R01CA047006-31 Epstein-Barr Virus Nuclear Protein B Cell Growth Transformation ZHAO, BO BRIGHAM AND WOMEN'S HOSPITAL MA $532,500
Hodgkin's Disease 2018 NCI 1K08CA230319-01 Defining the Biological and Mechanistic Implications of XPO1 Mutations in Hematologic Malignancies TAYLOR, JUSTIN SLOAN-KETTERING INST CAN RESEARCH NY $244,470
Hodgkin's Disease 2018 NCI 1R01CA232616-01 EBV LMP1/LMP2A Proteins Promote Hodgkin-like Lymphomas in Humanized Mice KENNEY, SHANNON UNIVERSITY OF WISCONSIN-MADISON WI $381,507
Hodgkin's Disease 2018 NCI 1K08CA234232-01 Treatment Modifications, Outcomes and Provider Decision Making in the Management of Subsequent Breast Cancers Among Survivors of Childhood Cancer TURCOTTE, LUCIE UNIVERSITY OF MINNESOTA MN $179,555
Hodgkin's Disease 2018 NCI 261200800001E-132-0-36 Repository Services for epidemiology studies HEIMBROOK, DAVID LEIDOS BIOMEDICAL RESEARCH, INC. MD $2,735,000
Hodgkin's Disease 2018 NCI 3P30CA006973-55S1 8084 Hematologic Malignancies and BMT Program - 02 AMBINDER, RICHARD JOHNS HOPKINS UNIVERSITY MD $2,068
Hodgkin's Disease 2018 NCI 3P30CA006973-55S2 8084 Hematologic Malignancies and BMT Program - 02 AMBINDER, RICHARD JOHNS HOPKINS UNIVERSITY MD $6,864
Hodgkin's Disease 2018 NCI 1ZIACP010131-23 Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents KITAHARA, CARI NIH $4,577,741
Hodgkin's Disease 2018 NCI 1ZIABC011070-11 Hematopathology Diagnosis JAFFE, ELAINE NIH $904,289


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer